Chinese herbal medicine suppresses invasion-promoting capacity of cancer-associated fibroblasts in pancreatic cancer

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chen, Lianyu ^a,b   Qu, Chao ^a,b   Chen, Hao ^a,b   Xu, Litao ^a,b   Qi, Qi ^a,b   Luo, Jianmin ^b   Wang, Kun ^a,b   Meng, Zhiqiang ^a,b   Chen, Zhen ^a,b   Wang, Peng ^a,b   Liu, Luming ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; HERBACEOUS AGENT; INTERLEUKIN 8; QYHJ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER INHIBITION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FIBROBLAST; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES, CXC; DRUGS, CHINESE HERBAL; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84899737285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096177     Document Type: Article

References (36)

1. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20: 1218-1249. (Pubitemid 43727584)
2. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363: 1049-1057. (Pubitemid 38410779)
3. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54: 8-29. (Pubitemid 38443417)
4. Tchou J, Kossenkov AV, Chang L, Satija C, Herlyn M, et al. (2012) Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles. BMC Med Genomics 5: 39.
5. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926. (Pubitemid 351206771)
6. Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, et al. (2008) Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecol Oncol 110: 99-109.
7. Merika EE, Syrigos KN, Saif MW (2012) Desmoplasia in pancreatic cancer. Can we fight it? Gastroenterol Res Pract 2012: 781765.
8. Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, et al. (2011) Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 10: 2521-2528.
9. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
10. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
11. Chen Z, Chen LY, Wang P, Dai HY, Gao S, et al. (2012) Tumor Microenvironment Varies under Different TCM ZHENG Models and Correlates with Treatment Response to Herbal Medicine. Evid Based Complement Alternat Med 2012: 635702.
12. Yin JH, Shi WD, Zhu XY, Chen Z, Liu LM (2012) Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF. Integr Cancer Ther 11: 37-47.
13. Wang P, Chen Z, Meng ZQ, Luo JM, Lin JH, et al. (2010) Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer. Integr Cancer Ther 9: 50-58.
14. Ouyang H, Wang P, Meng Z, Chen Z, Yu E, et al. (2011) Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas 40: 120-125.
15. Walter K, Omura N, Hong SM, Griffith M, Goggins M (2008) Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol Ther 7: 882-888.
16. Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, et al. (2009) Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function. Carcinogenesis 30: 1497-1506.
17. Zhang J, Wang P, Ouyang H, Yin J, Liu A, et al. (2013) Targeting Cancer-Related Inflammation: Chinese Herbal Medicine Inhibits Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. PLoS One 8: e70334.
18. Feng Q, Gou XJ, Meng SX, Huang C, Zhang YQ, et al. (2013) Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro. Evid Based Complement Alternat Med 2013: 184358.
19. Wang P, Chen L, Zhang J, Chen H, Fan J, et al. (2013) Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene.
20. Muerkoster S, Wegehenkel K, Arlt A, Witt M, Sipos B, et al. (2004) Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64: 1331-1337. (Pubitemid 38235601)
21. Sato N, Maehara N, Goggins M (2004) Gene expression profiling of tumorstromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res 64: 6950-6956. (Pubitemid 39331004)
22. Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, et al. (2013) Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer. PLoS One 8: e55146.
23. Kinoshita T, Ishii G, Hiraoka N, Hirayama S, Yamauchi C, et al. (2013) Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma. Cancer Sci 104: 409-415.
24. Schoppmann SF, Jesch B, Riegler MF, Maroske F, Schwameis K, et al. (2013) Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp Metastasis 30: 441-446.
25. Zhu Q, Han X, Peng J, Qin H, Wang Y (2012) The role of CXC chemokines and their receptors in the progression and treatment of tumors. J Mol Histol 43: 699-713.
26. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, et al. (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14: 1049-1055.
27. Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ (2011) Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer 11: 196.
28. Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128: 2527-2535.
29. Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-1331.
30. Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N (2013) Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. Prostate 73: 941-951.
31. Frick VO, Rubie C, Wagner M, Graeber S, Grimm H, et al. (2008) Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. Pancreatology 8: 488-497.
32. Bandapalli OR, Ehrmann F, Ehemann V, Gaida M, Macher-Goeppinger S, et al. (2012) Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis. Cytokine 57: 46-53.
33. Nishikawa R, Suzumori N, Nishiyama T, Nishikawa H, Arakawa A, et al. (2012) Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer. Eur J Gynaecol Oncol 33: 138-141.
34. Dong QM, Zhang JQ, Li Q, Bracher JC, Hendricks DT, et al. (2011) Clinical significance of serum expression of GRObeta in esophageal squamous cell carcinoma. World J Gastroenterol 17: 2658-2662.
35. Killian PH, Kronski E, Michalik KM, Barbieri O, Astigiano S, et al. (2012) Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and 22. Carcinogenesis 33: 2507-2519.
36. Kavandi L, Collier MA, Nguyen H, Syed V (2012) Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell Biochem 113: 3143-3152.